Pages

Monday, December 29, 2003

Subcommittee on Health, Committee on Energy and Commerce

The current personal importation policy permits the exercise of enforcement discretion to allow entry of an unapproved prescription drug only if the intended use is for a serious condition for which effective treatment may not be available domestically; the product is considered not to represent an unreasonable risk; the product is for personal use; there is no known commercialization or promotion to U.S. residents by those involved in the distribution of the product; and the individual seeking to import the product affirms in writing that it is for the patient's own use and provides the name and address of the U.S. licensed doctor responsible for his or her treatment with the product or provides evidence that the product is for the continuation of a treatment begun in a foreign country.

No comments:

Post a Comment

Hi, thanks for your sweetness and consideration to comment on my post. However, I have disabled anonymous comment for obvious reasons. Leave a honest comment and we can discuss it, toss it back and forth like a ball across a tennis court!